STOCK TITAN

Kamada (NASDAQ: KMDA) VP reports initial share and option holdings

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
3

Rhea-AI Filing Summary

Kamada Ltd VP of Marketing & Sales Hanni Neheman has filed an initial ownership report showing ordinary shares and stock options in the company. The filing lists direct ownership of 3,417 ordinary shares and several option grants over ordinary shares with exercise prices of $6.15 and $7.55 per share, expiring between 2028 and 2035. The options are exercisable using a net-exercise method, and the exercise prices shown in U.S. dollars reflect a translation from New Israeli Shekels based on the Bank of Israel exchange rate as of March 13, 2026.

Positive

  • None.

Negative

  • None.
SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Neheman Hanni

(Last) (First) (Middle)
9 HAZAV ST.

(Street)
ZOFIT L3 4492500

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
03/16/2026
3. Issuer Name and Ticker or Trading Symbol
KAMADA LTD [ KMDA ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
VP, Marketing & Sales
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares 3,417 D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Options to purchase Ordinary Shares(1) 02/28/2026 08/28/2028 Ordinary Shares 15,000 $6.15(2) D
Options to purchase Ordinary Shares(1) 10/22/2026 10/22/2035 Ordinary Shares 15,000 $7.55(2) D
Options to purchase Ordinary Shares(1) 10/22/2027 10/22/2035 Ordinary Shares 15,000 $7.55(2) D
Options to purchase Ordinary Shares(1) 10/22/2028 10/22/2035 Ordinary Shares 15,000 $7.55(2) D
Options to purchase Ordinary Shares(1) 10/22/2029 10/22/2035 Ordinary Shares 15,000 $7.55(2) D
Explanation of Responses:
1. These options to purchase ordinary shares are exercisable using a net-exercise method
2. All exercise prices presented in U.S. dollars represent a convenience translation from NIS based on the representative exchange rate of the Bank of Israel as of March 13, 2026.
/s/ Hanni Neheman 03/16/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What does Kamada (KMDA) VP Hanni Neheman report in this Form 3?

Hanni Neheman, Kamada’s VP of Marketing & Sales, reports initial beneficial ownership of ordinary shares and stock options. The filing shows directly held shares plus multiple option grants over ordinary shares at specified exercise prices and expiration dates.

How many Kamada (KMDA) ordinary shares does Hanni Neheman directly own?

The Form 3 shows direct ownership of 3,417 Kamada ordinary shares. These are held outright, separate from the reported option grants, and represent Neheman’s current visible equity stake in the company’s ordinary share capital.

What stock options are reported for Kamada (KMDA) VP Hanni Neheman?

The filing lists several grants of options to purchase Kamada ordinary shares, including a grant with 15,000 underlying shares at an exercise price of $6.15 expiring in 2028, plus additional grants at $7.55 expiring in 2035.

How are Kamada (KMDA) options exercisable for Hanni Neheman?

The Form 3 states that Neheman’s options are exercisable using a net-exercise method. In a net exercise, the holder typically receives fewer shares instead of paying cash, with some shares withheld to cover the exercise cost.

Why are Kamada (KMDA) option exercise prices shown in U.S. dollars?

Exercise prices are originally denominated in New Israeli Shekels but are presented in U.S. dollars as a convenience translation. The conversion uses the Bank of Israel representative exchange rate as of March 13, 2026.

Does this Kamada (KMDA) Form 3 show any recent insider buying or selling?

No buy or sell transactions are reported; it is an initial ownership statement. The entries are classified as holdings, summarizing Neheman’s existing ordinary share and option positions rather than recent market trades.
Kamada Ltd

NASDAQ:KMDA

View KMDA Stock Overview

KMDA Rankings

KMDA Latest News

KMDA Latest SEC Filings

KMDA Stock Data

501.83M
31.45M
Drug Manufacturers - Specialty & Generic
Healthcare
Link
Israel
Rehovot